Related Experiment Videos
Factors Associated with Active Tuberculosis Disease in Patients with Lung Cancer Following Immune Checkpoint Blockade
Xiao Wang1, Yu-Xiao Wu1,2, Wei-Ping Hu1
1Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Background:
Immune checkpoint inhibitors (ICIs) have revolutionized lung cancer treatment by improving survival in patients with advanced disease and expanding treatment options for patients with early-stage disease. However, ICIs may increase the risk of active tuberculosis (TB) disease. Our study investigated potential warning markers for active TB disease in patients with lung cancer receiving ICIs, aiming to inform management strategies.
Methods:
A retrospective cohort study at Zhongshan Hospital of Fudan University reviewed 4157 solid tumor patients treated with ICIs from January 2021 to February 2023. A total of 118 patients with lung cancer were included, either diagnosed with latent TB infection or non-active TB, or had a confirmed TB history before the start of ICI therapy. The primary outcome was the occurrence of active TB disease, with follow-up extending to February 1, 2024. Propensity score matching (PSM) was applied to account for differences in baseline characteristics.
Results:
Among the 118 patients, 5 (4.24%) developed active TB. Post-PSM Fisher's exact test suggested that confirmed TB history (RR: 4.00, p = 0.029), high tumor necrosis factor-alpha (RR: 8.64, p = 0.030), high interleukin-2 receptor (RR: 6.00, p = 0.031), low white blood cell count (RR: 8.50, p = 0.009), and low lymphocyte count (RR: 9.33, p = 0.014) were significantly associated with active TB disease. Among patients who developed active TB disease, two had a decrease in T-SPOT.TB spot count after receiving ICI therapy.
Conclusion:
The identification of significant factors associated with active TB underscores the importance of vigilant monitoring and early intervention. A decrease in the T-SPOT.TB spot count may not necessarily reflect an improvement in TB infection, but may instead indicate potential TB activation.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis